Advanced search×

Plasma clusterin and the risk of Alzheimer disease.

JAMA 305(13):1322-6 (2011) PMID 21467285

Variants in the clusterin gene are associated with the risk of Alzheimer disease (AD) and clusterin levels have been found to be increased in brain and cerebrospinal fluid of patients with AD. Plasma clusterin was reported to be associated with brain atrophy, baseline disease severity, and rapid clinical progression in patients with AD.

DOI: 10.1001/jama.2011.381
Version: za2963e q8za9 q8zbc q8zc7 q8zd7 q8zea q8zf1 q8zg5

Similar articles you may find interesting…

  1. Real-life effectiveness and tolerability of rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: The EMBRAC...

    Curr Med Res Opin (2013) PMID 23647369

    Rivastigmine transdermal patch is effective in maintaining cognitive function over 18 months of treatment in patients with mild-to-moderate AD. The safety profile was comparable to the data in the Canadian product monograph. Lack of a comparator group is a potential limitation of the study....
  2. Virological and Immunological Characteristics of Human Cytomegalovirus Infection Associated with Alzheimer's Disease.

    J Infect Dis (2013) PMID 23661800

    Serum, CSF and cryopreserved lymphocytes from subjects in the Rush Alzheimer's Disease Center Religious Orders Study were analyzed for associations between CMV infection and clinical and pathological markers of Alzheimer's Disease (AD). CMV antibody levels were associated with neurof...
  3. Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel Disease.

    Dig Dis Sci (2013) PMID 23649377

    Mean ± standard deviation (SD) of OCTT in patients of IBD was significantly higher as compared to controls. Furthermore, OCTT was significantly higher in CD patients as compared to UC patients. It was also observed that occurrence of SIBO was significantly higher in IBD patients as compared to co...